Cancer Biology and Epigenetics Group, Research Center, Portuguese Oncology Institute of Porto (CI-IPOP), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Int J Mol Sci. 2019 Jan 13;20(2):297. doi: 10.3390/ijms20020297.
Bladder cancer is one of the most incident neoplasms worldwide, and its treatment remains a significant challenge, since the mechanisms underlying disease progression are still poorly understood. The epithelial to mesenchymal transition (EMT) has been proven to play an important role in the tumorigenic process, particularly in cancer cell invasiveness and metastatic potential. Several studies have reported the importance of epigenetic mechanisms and enzymes, which orchestrate them in several features of cancer cells and, specifically, in EMT. In this paper, we discuss the epigenetic enzymes, protein-coding and non-coding genes, and mechanisms altered in the EMT process occurring in bladder cancer cells, as well as its implications, which allows for improved understanding of bladder cancer biology and for the development of novel targeted therapies.
膀胱癌是全球发病率最高的肿瘤之一,其治疗仍然是一个重大挑战,因为疾病进展的机制仍未得到很好的理解。上皮间质转化(EMT)已被证明在肿瘤发生过程中发挥重要作用,特别是在癌细胞的侵袭性和转移潜能方面。多项研究报道了表观遗传机制和酶的重要性,它们在癌细胞的多个特征中以及 EMT 中起协调作用。在本文中,我们讨论了 EMT 过程中发生的膀胱癌细胞中表观遗传酶、蛋白编码和非编码基因以及改变的机制,及其意义,这有助于更好地理解膀胱癌生物学,并开发新的靶向治疗方法。